Valeant Pharmaceuticals (VRX +0.4%) completes its executive management team by naming Laizer...

|About: Valeant Pharmaceuticals I... (VRX)|By:, SA News Editor

Valeant Pharmaceuticals (VRX +0.4%) completes its executive management team by naming Laizer Kornwasser as EVP/Group Chairman with responsibility for the firm's Canadian operations, U.S. Neurology, and various other U.S. functions, including managed care and distribution. Kornwasser was a senior exec at Medco Health prior to its acquisition by Express Scripts. (Recent other Valeant appointments) (PR)